Palatin Technologies (OTCMKTS:PTNT) Share Price Crosses Above 200 Day Moving Average – What’s Next?

Palatin Technologies, Inc. (OTCMKTS:PTNT) shares passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $18.58 and traded as high as $24.51. Palatin Technologies shares last traded at $24.51, with a volume of 14 shares traded.

Palatin Technologies Trading Down 0.7%

The stock has a fifty day moving average of $24.90 and a two-hundred day moving average of $18.62. The stock has a market capitalization of $973,200.00, a price-to-earnings ratio of -15.70 and a beta of -1.36.

Palatin Technologies Company Profile

Palatin Technologies, Inc, a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing oral PL8177, a selective MC1r agonist peptide that is in Phase 2 clinical trial for the treatment of inflammatory bowel diseases. In addition, the company engages in the development of PL9643, a peptide melanocortin agonist active at multiple MCrs, including MC1r and MC5r for anti-inflammatory ocular indications, such as dry eye disease, which is in Phase 3 clinical trial; and melanocortin peptides for diabetic retinopathy.